Target intelligence / Profile preview

RNA, U6 small nuclear 845, pseudogene (RNU6-845P)

Target
RNU6-845P
Molecular classification
Other (Pseudogene)
01

Overview

RNU6-845P is a human pseudogene homologous to U6 small nuclear RNA (U6 snRNA), a non-coding RNA crucial for spliceosome function in pre-mRNA splicing[1][3][5]. The U6 snRNA is among the core small nuclear RNAs (snRNAs) that help catalyze intron removal during the maturation of messenger RNA in the nucleus. Pseudogenes like RNU6-845P are considered non-functional copies or derivatives that have lost their ability to produce functional RNA or protein, typically arising from gene duplication or retrotransposition. While some pseudogenes can exert regulatory influences on gene expression, there is no published evidence that RNU6-845P is involved in such functions or is clinically relevant as a disease marker or drug target. Additional notes: - The U6 snRNA itself (not the pseudogene) is highly conserved and essential for splicing, but RNU6-845P does not produce the functional RNA[3][1][5]. - There are many U6 pseudogenes throughout the human genome; most are transcriptionally inactive[5]. In summary: RNU6-845P is a non-functional pseudogene copy of the U6 snRNA gene, not a bona fide therapeutic target, with no recognized role in disease, no known drug interactions, and no safety or biomarker relevance based on current knowledge[3][1][5].

Other names
RNU6-845P
02

Mechanism of action

null

03

Biological functions

null (no confirmed biological function; pseudogenes are typically non-functional but may occasionally have regulatory roles)
04

Disease associations

Other (no established disease association; pseudogenes sometimes serve as biomarkers or play regulatory roles, but no direct evidence for RNU6-845P)

Beyond the preview

Go deeper on RNA, U6 small nuclear 845, pseudogene (RNU6-845P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 845, pseudogene (RNU6-845P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call